Skip to content

Clinical trials

Observational COVID-19 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Observational Country / region: China Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
202042
202115
202232
202335
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status72
Completed45
Recruiting8
Active, not recruiting3
Withdrawn2
Terminated1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tongji Hospital7
RenJi Hospital6
The Second Affiliated Hospital of Chongqing Medical University6
Huashan Hospital4
Ruijin Hospital4
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
Chinese University of Hong Kong3
Peking Union Medical College Hospital3
Qilu Hospital of Shandong University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19132
Infections5
Postoperative Complications5
Post-Acute COVID-19 Syndrome4
Liver Diseases3
Breast Neoplasms2
Cardiovascular Diseases2
Coinfection2
Cytokine Release Syndrome2
HIV Infections2

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.